Literature DB >> 22296585

The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies.

Spero R Cataland, Shangbin Yang, Haifeng M Wu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22296585     DOI： 10.1111/j.1365-2141.2012.09032.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Response to "Predictors of survival in thrombotic thrombocytopenic purpura" Haematologica 2013;98(5):e58.

Authors:  Paul Coppo
Journal:  Haematologica       Date:  2013-07       Impact factor: 9.941

2.  Complement-mediated thrombotic microangiopathy associated with lupus nephritis.

Authors:  Mi Hee Park; Nicholas Caselman; Scott Ulmer; Ilene Ceil Weitz
Journal:  Blood Adv       Date:  2018-08-28

3.  Modified Ham test for atypical hemolytic uremic syndrome.

Authors:  Eleni Gavriilaki; Xuan Yuan; Zhaohui Ye; Alexander J Ambinder; Satish P Shanbhag; Michael B Streiff; Thomas S Kickler; Alison R Moliterno; C John Sperati; Robert A Brodsky
Journal:  Blood       Date:  2015-04-10       Impact factor: 22.113

4.  A rare case of thrombotic microangiopathy triggered by acute pancreatitis.

Authors:  Kevin Singh; Ahmed Jamal Nadeem; Behzad Doratotaj
Journal:  BMJ Case Rep       Date:  2017-05-15

Review 5.  Thrombotic microangiopathy and associated renal disorders.

Authors:  Thomas Barbour; Sally Johnson; Solomon Cohney; Peter Hughes
Journal:  Nephrol Dial Transplant       Date:  2012-07       Impact factor: 5.992

6.  A non-invasive laboratory panel as a diagnostic and prognostic biomarker for thrombotic microangiopathy: development and application in a Chinese cohort study.

Authors:  Tao Zhang; Huimei Chen; Shaoshan Liang; Dacheng Chen; Chunxia Zheng; Caihong Zeng; Haitao Zhang; Zhihong Liu
Journal:  PLoS One       Date:  2014-11-05       Impact factor: 3.240

7.  Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.

Authors:  Xuan Yuan; Eleni Gavriilaki; Jane A Thanassi; Guangwei Yang; Andrea C Baines; Steven D Podos; Yongqing Huang; Mingjun Huang; Robert A Brodsky
Journal:  Haematologica       Date:  2016-11-03       Impact factor: 9.941

8.  Thrombotic Thrombocytopenic Purpura Triggered by Acute Myeloid Leukemia: A Case Report.

Authors:  Ijele Adimora; Cristhiam M Rojas Hernandez
Journal:  Am J Case Rep       Date:  2022-08-30

9.  The role of ADAMTS-13 activity and complement mutational analysis in differentiating acute thrombotic microangiopathies.

Authors:  E H Phillips; J P Westwood; V Brocklebank; E K S Wong; J O Tellez; K J Marchbank; S McGuckin; D P Gale; J Connolly; T H J Goodship; D Kavanagh; M A Scully
Journal:  J Thromb Haemost       Date:  2016-01-11       Impact factor: 5.824

10.  HELLP Syndrome, Thrombotic Thrombocytopenic Purpura or Both: Appraising the Complex Association and Proposing a Stepwise Practical Plan for Differential Diagnosis.

Authors:  Mohamad K Ramadan; Dominique A Badr; Manal Hubeish; Saadeddine Itani; Haneen Hijazi; Anas Mogharbil
Journal:  J Hematol (Brossard)       Date:  2017-01-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.